| Financial Year |
March 31 2023 |
| Monetary Funds |
9,989,432,967.91 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,975,687,007.48 |
| Advances to Suppliers |
218,863,586.99 |
| Other Receivables |
268,935,010.41 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
31,540,499.15 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
8,891,969.17 |
| Total Current Assets |
12,493,351,041.11 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
34,300,000.00 |
| Investment Properties |
-- |
| Fixed Assetes |
3,676,247,395.44 |
| Under-construction Projects |
276,311,869.87 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
320,130,777.34 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
492,660,938.19 |
| Deferred Income Tax Assets |
90,025,686.66 |
| Other Non-Current Assets |
315,814,107.11 |
| Sub-Total of Non-Current Assets |
13,813,764,022.65 |
| Total Assets |
26,307,115,063.76 |
| Short-Term Loans |
542,864,300.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,221,113,324.21 |
| Accounts Received In Advance |
7,593,983.87 |
| Employee Compensation Payable |
606,536,513.16 |
| Taxes Payable |
351,956,395.03 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
632,812,275.95 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,319,218,861.39 |
| Other Current Liabilities |
11,383,514.26 |
| Sub-Total of Current Liabilities |
5,732,221,334.13 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
4,052,092.56 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,998,612,778.17 |
| Total Liabilities |
10,730,834,112.30 |
| Paid-In Capital(Or Share Stock) |
1,587,555,556.00 |
| Capital Surplus |
3,662,846,469.02 |
| Surplus Reserve |
512,772,924.07 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
8,626,857,136.45 |
| Minority Stockholder's Interest |
1,291,608,649.33 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
14,284,672,302.13 |
| Owner's Equity（Stockholder's Equity） |
15,576,280,951.46 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
26,307,115,063.76 |
